DKDilrabo Kayumova

Dilrabo Kayumova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dilrabo Kayumova has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Expert Consensus on Optimizing the Strategy for the Prevention of Vitamin D Deficiency in Central Asia: From Scientific Evidence to Real-World Practice

    by Pawel Pludowski, Larisa Makalkina, Rimma Bazarbekova, Ainur Dossanova, Galymzhan Togizbayev, Gulzhan Gabdulina, Galina Grebennikova, Assel Jaimbetova, Dilrabo Kayumova, Sevara Irgasheva, et al.

    Background/Objectives: Vitamin D deficiency and insufficiency represent a widespread problem in the majority of Central Asian countries, attributable to the geographical location of the region, urbanization, and dietary patterns of the population. Given that vitamin D not only participates in the regulation of calcium and phosphate metabolism but also exerts pleiotropic effects on various organs and systems, its insufficiency and deficiency are associated with a broad spectrum of pathological conditions, ranging from asymptomatic manifestations to severe clinical symptoms, including the development of autoimmune diseases, metabolic disorders, cardiovascular, gynecological and reproductive, and rheumatological conditions. The development of national and interdisciplinary guidelines addressing the diagnosis, prevention of insufficiency, and correction of vitamin D deficiency in the countries of Central Asia represents an important step toward the establishment of effective preventive programs and treatment strategies, which may contribute to a reduction in the prevalence of diseases associated with vitamin D deficiency. The aim of the present work is to formulate a resolution capturing the conclusions and recommendations derived from an interdisciplinary expert discussion. Methods: An Expert Council meeting with the participation of specialists in endocrinology, obstetrics and gynecology, rheumatology, clinical pharmacology, and other medical disciplines from Central Asian and European countries was conducted in Almaty (Kazakhstan) on 18 June 2025. During this meeting, the pleiotropic action of vitamin D was extensively discussed basing on RCTs and observational studies. Results: Following the Expert Council meeting, current international clinical guidelines, scientific research data, and relevant epidemiological evidence were reviewed, leading to the formulation of a resolution that reflects the agreed-upon recommendations for the prevention of vitamin D insufficiency and the correction of vitamin D deficiency across different age groups according to baseline vitamin D metabolite levels. Conclusions: The expert discussion emphasized the need for unified interdisciplinary approaches to the diagnosis, correction, and prevention of vitamin D deficiency in the countries of Central Asia. The proposed recommendations may serve as a foundation for the development of national clinical protocols and the implementation of effective preventive and therapeutic strategies in the countries of Central Asia.

  • Open Access

    Resolution of the VII International Forum of Experts on Menopausal Hormone Therapy

    by T.F. Tatarchuk, N.Y. Pedachenko, G.O. Grebennikova, O.L. Gromova, D.T. Kayumova, O.G. Yashina, L.R. Agababyan, L.M. Begimbekova, F.A. Gafurova, M.A. Gegechkori, et al.

    The VII International Forum of Experts on Menopausal Hormone Therapy (MHT) was held in Kyiv on November 18, 2025. The modern approach to the MHT prescription is not to resolve the issue of its appropriateness, but to choose the optimal form for a particular woman. Different routes of hormone administration have different pharmacokinetic properties and effects on metabolism, the coagulation system, and women’s somatic health. The recommendations of the European Menopause and Andropause Society emphasize the appropriateness of using combined MHT to improve the glycemic profile and delay the development of diabetes mellitus, with a preference for metabolically neutral progestogens – progesterone and dydrogesterone.Transdermal estrogens enter the systemic circulation directly, minimizing the effect on the liver and coagulation, which makes them the method of choice for women with an increased risk of venous thrombosis, obesity, or hypertriglyceridemia. At the same time, the effectiveness of transdermal MHT is characterized by significant interindividual variability.MHT is an effective antiresorptive method for the prevention of osteoporosis and fractures. Clinical studies demonstrate a significant increase in bone mineral density and a reduction in the risk of fractures with the use of MHT, particularly the combination of estradiol and dydrogesterone. Timely initiated MHT (within the first 10 years after menopause) is also associated with a decrease in all-cause mortality, cardiovascular complications, and neurodegenerative diseases. The individual choice of the form of MHT is a key factor in its safety and clinical efficacy.Particular attention should be paid to oncological safety, particularly the risk of breast cancer, when selecting MHT in patients using a levonorgestrel-releasing intrauterine system. Data from systematic reviews and meta-analyses indicate that the use of estrogens does not increase this risk, while it largely depends on the type of progestogen. Progesterone and dydrogesterone have the most favorable safety profile for the breast compared with synthetic gestagens, which is confirmed by the results of large-scale studies.Psychoemotional and sexual disorders (anxiety, depression, sleep disorders, and decreased libido) are common in perimenopause and are largely due to systemic estrogen deficiency, which affects neurometabolic, vascular, and neuroendocrine homeostasis. The high frequency of these disorders justifies the need for comprehensive diagnostic assessment and individualized MHT in perimenopausal women.

  • Open Access

    The effect of three pairs of uterine vessels ligation on uterine and ovarian blood supply in patients with pathological blood loss

    by N. M. Inoyatova, D. T. Kayumova

    Introduction. To stop obstetric bleeding, organ-preserving surgical methods are used, one of which is ligation of three-layered uterine vessels. The effectiveness of organ-preserving methods comprises up to 94 %. The function of any organ depends on proper blood supply, and therefore the state of the reproductive function in women undergone organ-preserving operations is an object for further investigation. Aim: study of blood flow in the uterus and ovaries after ligation of three pairs of uterine vessels in women with pathological blood loss. Materials and Methods . A prospective controlled study was conducted that included main group (41 patients after ligation of three pairs of uterine vessels due to pathological blood loss during operative delivery) and control group (25 women after cesarean section without pathological blood loss and ligation of three pairs of uterine vessels). Doppler study of uterine arteries and central ovarian blood flow was performed by assessing angle-independent parameters – pulsation index (PI), resistance index (RI). Volumetric blood flow in uterine arteries and uterine arterial perfusion index were calculated. Results . The average age of patients in main and control group was 30.00 ± 0.84 years and 25.96 ± 0.99 years (p = 0.003), respectively. The volume of blood loss in main vs. control group was 2.7 times greater (p < 0.001). Assessing PI and RI in the uterine arteries showed highly resistant blood flow, PI and RI significantly increased by 1.6 and by 1.4 times, respectively, compared with control group (p < 0.001).Calculation of volumetric blood flow in the uterine arteries in patients from main group showed a decline by 18.2–22.6 % compared to control group. It resulted in decreased arterial perfusion index of the uterus in group of patients underwent organ-preserving operations for pathological blood loss by 30.2 %. PI and IR magnitude in intraovarian blood flow turned out to increase by 2 and 1.4 times, respectively (p < 0.05). Conclusion . The identified highly resistant blood flow in the uterus and ovaries may further result in anovulatory cycle formation due to impaired organ hemodynamics able to lead to developing ovarian insufficiency.